Biotia

Biotia, a NYC-based clinical metagenomics solutions provider, raised $9M in an oversubscribed financing round. Investors included Convergent Ventures, DigitalDx Ventures, Cloquet Capital Partners, Continuum Health Ventures, and others. Michele Colucci, CEO of DigitalDx Ventures, joined as board chair. The company, a spinout from Cornell Tech's Jacobs Institute, provides infectious disease diagnostic testing available across all 50 U.S. states, with initial focus on women's health and orthopedics.